| |
| | Process for diagnosing erectile dysfunction, and related methods of treatment - Patent 5482039 |
 | | The method of claim 1, wherein the vasodilating agent is selected from the group consisting of nitrates, long- and short-acting.alpha.-blockers, calcium blockers, ergot alkaloids, chlorpromazine, haloperidol, yohimbine, natural and synthetic vasoactive prostaglandins and their analogs, vasoactive intestinal peptides, dopamine agonists, opioid antagonists, and mixtures thereof. |
 | | The method of claim 40, wherein the vasodilating agent is selected from the group consisting of nitrates, long- and short-acting.alpha.-blockers, calcium blockers, ergot alkaloids, chlorpromazine, haloperidol, yohimbine, natural and synthetic vasoactive prostaglandins and their analogs, vasoactive intestinal peptides, dopamine agonists, opioid antagonists, and mixtures thereof. |
 | | The method of claim 34, wherein the vasodilating agent is selected from the group consisting of nitrates, long- and short-acting.alpha.-blockers, calcium blockers, ergot alkaloids, chlorpromazine, haloperidol, yohimbine, natural and synthetic vasoactive prostaglandins and their analogs, vasoactive intestinal peptides, dopamine agonists, opioid antagonists, and mixtures thereof. |
| www.freepatentsonline.com /5482039.html (7330 words) |
|